Day 2 – 22 September 2021
| Interactive Poster session 3 | |
| 09:00–09:05 | Break |
| Industry Symposium 3 | |
| 10:05–10:20 | Coffee Break |
| 10:20–11:20 | Industry Symposium 4 |
| 11:20–11:25 | Break |
| 11:25–12:10 | Plenary Session 5 The KDIGO IgAN & IgAV Update Jürgen Floege: Formulation of the 2021 Guideline and what to expect in the future Heather Reich: Key updates in the 2021 IgAN & IgAV Guideline Sydney Tang: Key unmet needs identified following the KDIGO guideline review |
| 12:10–12:40 | Lunch Break |
| 12:40–13:40 | Free Communications 2 Expert Panel: What are the key questions we still need to answer in IgAN? |
| 13:40–13:45 | Break |
| 13:45–14:45 | Panel Discussion 2 |
| 14:45–14:50 | Break |
| 14:50–15:20 | Industry Symposium 6b |
| 15:20–15:25 | Break |
| 15:25–16:10 | Plenary Session 6 New targets for new therapies in IgAN & IgAV Yusuke Suzuki: Targeting pathogenic IgA production Hiddo L. Heerspink: Modulating non-immune pathways-how might this help? Dana Rizk: Inhibiting complement activation in IgAN |
| 16:10–16:25 | Coffee Break |
| 16:25–17:10 | Plenary Session 7 Improving patient stratification & prognostication – what do we need? Sean Barbour: How do we improve the IIGAN Risk Prediction Tool? Hitoshi Suzuki: What biomarkers are on the horizon that may help risk stratify patients with IgAN? Lesley Inker: How can we use big data from CKD to improve prognostication in IgAN? |
| 17:10–17:15 | Break |
| 17:15–18:00 | Plenary Session 8 Smarter Clinical Trial designs for IgAN Barbara Gillespie: How has COVID-19 changed our views on delivering clinical trials? Simon Carter: The Importance of Patient Reported Outcomes in IgAN Clinical Trial Design Adeera Levin: Novel clinical trial designs and what they could deliver in IgAN |
| 18:00–18:05 | Break |
| 18:05–19:05 | Industry Symposium 4 |
| 19:05–19:10 | Break |
| 19:10–20:10 | Industry Symposium 3 |
| 20:10–20:15 | Break |
| 20:15–21:00 | Interactive Poster session 4 |
|
All times in the symposium programme are in Central European Summer Time – CEST (UTC + 2). |
|
